Topical Hamelia Patens Extract for Peripheral Neuropathy Pain
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for peripheral neuropathy lack effective topical formulations for symptomatic relief, with only systemic drug therapies approved by the FDA, and no topical medications have been proven effective for this condition.
Innovation Solution
Development of topical compositions containing extracts from the Hamelia patens plant, including compounds like apigenin-7-o-beta d-glucuronide and rosmarinic acid, combined with dermatologically acceptable carriers for application to human skin to provide pain relief.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If systemic drug therapies are used to treat peripheral neuropathy pain, then pain relief can be achieved, but the treatment lacks patient-friendliness and involves systemic side effects
Solution Approach 1:
The patent uses topical application as an intermediary delivery method between systemic administration and direct nerve intervention. The topical composition serves as a mediator that delivers active ingredients through the skin to affect peripheral nerves locally, avoiding systemic circulation while still providing effective pain relief.
Solution Approach 2:
The invention applies treatment locally to the affected area through topical application rather than systemic distribution. This allows the active ingredients to concentrate at the site of neuropathy where they are needed most, providing targeted pain relief while minimizing exposure to the rest of the body and reducing side effects.
2Ease of operation
If topical anesthetics like benzocaine, lidocaine, and camphor are applied to relieve pain, then some symptomatic relief can be achieved, but these formulations are not effective for peripheral neuropathy specifically
Solution Approach 1:
The patent changes the chemical parameters of the topical formulation by using plant-derived active ingredients with specific chemical compositions that differ from conventional anesthetics. These natural compounds have different mechanisms of action and pharmacological properties that make them specifically effective for peripheral neuropathy while maintaining topical application convenience.
Solution Approach 2:
The invention uses composite plant extracts containing multiple active compounds working synergistically. Rather than a single synthetic anesthetic, the topical composition combines various natural ingredients that together provide enhanced effectiveness for peripheral neuropathy while maintaining the ease of topical application.
3Reliability
If no effective topical formulation exists for peripheral neuropathy, then systemic therapies must be used, but this increases treatment complexity and side effects
Solution Approach 1:
The patent segments the treatment approach by separating local neuropathy treatment from systemic management. The topical formulation addresses the local symptomatic relief needs independently, allowing patients to treat affected areas directly without relying on systemic medications, thereby simplifying the overall treatment regimen.
Data Source
AI summary
Methods are provided for relieving pain associated with peripheral neuropathy, by topical application to human skin of a topical composition comprising Hamelia patens extract in combination with a dermatologically-acceptable carrier. According to methods of the invention, the topical composition is applied to human skin at a sufficient concentration and for a sufficient time to relieve pain associated with peripheral neuropathy.